Fundraising FoxEntact Bio
Watertown, US · Founded 2021 · 5 known investors
Find your way into Entact Bio
Sign up to see every warm intro you have to Entact Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Entact Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Entact is a drug discovery company developing treatments for patients. It works in the biotechnology and therapeutics sector.
Founders & leadership
RT
Ruben TommasiChief Scientific Officer
MG
Michael GutchChief Operating Officer
AL
Alon LazarusNamed on SEC filing
Board
AS
Andrew SinclairBoard director
AF
PO
Pini OrbachBoard director
RG
OS
Investors · 5
venBio Partnerslisted by venBio PartnersSan Francisco
How we know: a partner's Signal profile · the VCSheet dataset · Not right? Tell us
AbingworthreportedLondon · $15M – $30M
How we know: a partner's Signal profile · Not right? Tell us
Arkin CapitalreportedHerzliya
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$50.3M disclosed across 2 rounds · 2024–2026
▶$10MraisedJun 2026 · 7 investors · BiotechnologyRule 506(b)
▶$10MraisedJun 2026 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrew SinclairDirector
- Anna FrenchDirector
- Pini OrbachDirector
- Victoria RichonExecutive Officer, Director, Promoter
- Richard GasterDirector
- Owen SmithDirector
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$40.3MraisedMay 2024 · 7 investors · BiotechnologyRule 506(b)
▶$40.3MraisedMay 2024 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Victoria RichonExecutive Officer, Director
- Owen SmithDirector
- Anna FrenchDirector
- Richard GasterDirector
- Alon LazarusDirector
- Andrew SinclairDirector
- Offering amount
- $40.3M
- Amount sold
- $40.3M
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
EncapsulateEncapsulate builds automated tumor-on-a-chip systems that test microtumors derived from patient biopsies against treatment regimens to predict how individual cancer patients will respond, delivering personalized insights in under seven days. It serves oncologists, pharmaceutical companies, and cancer researchers, drawing on a patient biobank for drug testing, patient stratification, and mechanism studies.
Engage BioEngageBio develops DNA-based medicines using proprietary non-viral delivery technology to achieve extended therapeutic expression from a single dose with low manufacturing complexity.
Inceptor BioInceptor Bio is a clinical-stage biotechnology company developing cell therapies for cancer, focused on solid tumors. Its OUTLAST platform reprograms T cells during manufacturing to withstand the tumor microenvironment, and its lead candidate is IB-T101.
Arsenal BiosciencesArsenal Biosciences is a clinical-stage company developing programmable cell therapies to treat solid tumors. The company uses computational and engineering approaches to create cancer medicines.
Companies working in the same space as Entact Bio.
Frequently asked questions
- What does Entact Bio do?
- Entact is a drug discovery company developing treatments for patients. It works in the biotechnology and therapeutics sector.
- Who are Entact Bio's investors?
- Entact Bio's investors include venBio Partners, Abingworth, Arkin Capital, Qiming Venture Partners, venBio Global Strategic.
- How much funding has Entact Bio raised?
- Entact Bio has disclosed $50.3M raised across 2 rounds.
- Where is Entact Bio headquartered?
- Entact Bio is headquartered in Watertown, US.